Gilead Sciences, Inc. 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:22 pm Sale |
2024-12-31 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC GILD |
1,521,312 3.600% |
-1,410,155 (-48.10%) |
Filing |
| 2023-10-19 3:33 pm Purchase |
2023-10-11 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC GILD |
2,931,467 6.700% |
2,931,467 (New Position) |
Filing |